Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Odonate Therapeutics, Inc. | 15,514,566 | reported | 23 Dec 2020 | tx 24+441,133 |
| NEOSE TECHNOLOGIES INC | 10,321,983 | reported | 24 Sept 2008 | tx 3+1,308,719−7,472,414 |
| PENWEST PHARMACEUTICALS CO | 6,371,498 | reported | 10 Mar 2009 | tx 5+1,305,662 |
| Vanda Pharmaceuticals Inc. | 5,619,058 | reported | 25 Sept 2008 | tx 3+1,780,852 |
| ARADIGM CORP | 5,380,000 | reported | 13 Oct 2008 | tx 2+25,000−5,310,000 |
| Northstar Neuroscience, Inc. | 4,757,038 | reported | 14 May 2008 | tx 11+1,137,819 |
| TCR2 THERAPEUTICS INC. | 4,344,800 | reported | 12 May 2023 | tx 2+44,948 |
| Mirati Therapeutics, Inc. | 1,181,400 | reported | 20 Sept 2013 | tx 2−36,898 |
| TAPESTRY PHARMACEUTICALS, INC | 1,118,047 | reported | 19 Feb 2008 | tx 6+111,686−969,086 |
| TRIMERIS INC | 318,432 | reported | 15 Dec 2008 | tx 20+140,000−145,518 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2023 | PURCHASE | TCR2 THERAPEUTICS INC. | 38,765 | 1.95 USD | first after silence |
| 12 May 2023 | PURCHASE | TCR2 THERAPEUTICS INC. | 6,183 | 1.95 USD | |
| 03 May 2023 | TENDER | Jounce Therapeutics, Inc. | 5,300,087 | 1.85 USD | |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 10,000 | 9737.70 USD | |
| 22 Aug 2022 | TENDER | LA JOLLA PHARMACEUTICAL CO | 9,607,934 | 6.23 USD | |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 12,000 | — | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 12,000 | — | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 30,000 | — | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 30,000 | 0.00 USD | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 10,000 | — | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 18,000 | — | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 10,000 | — | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 10,000 | — | deriv |
| 22 Aug 2022 | OTHER | LA JOLLA PHARMACEUTICAL CO | 10,000 | — | deriv |
| 22 Aug 2022 | TENDER | LA JOLLA PHARMACEUTICAL CO | 3,519.32 | — | deriv |
| 12 Jan 2022 | GRANT_AWARD | LA JOLLA PHARMACEUTICAL CO | 30,000 | 0.00 USD | deriv |
| 25 May 2021 | PURCHASE | LA JOLLA PHARMACEUTICAL CO | 95,597 | 3.77 USD | |
| 26 May 2021 | PURCHASE | LA JOLLA PHARMACEUTICAL CO | 166,932 | 4.26 USD | |
| 24 May 2021 | PURCHASE | LA JOLLA PHARMACEUTICAL CO | 104,403 | 3.68 USD | |
| 25 May 2021 | PURCHASE | LA JOLLA PHARMACEUTICAL CO | 31,782 | 3.83 USD | |
| 10 Dec 2020 | GRANT_AWARD | LA JOLLA PHARMACEUTICAL CO | 30,000 | 0.00 USD | deriv |
| 06 Jan 2020 | GIFT | HERON THERAPEUTICS, INC. /DE/ | 1,600,000 | 0.00 USD | |
| 07 Jan 2020 | GIFT | HERON THERAPEUTICS, INC. /DE/ | 520,299 | 0.00 USD | |
| 21 Dec 2020 | PURCHASE | Odonate Therapeutics, Inc. | 62,144 | 14.58 USD | |
| 22 Dec 2020 | PURCHASE | Odonate Therapeutics, Inc. | 37,856 | 14.58 USD |
3 purchases reported after at least 12 months of silence — most recent on 11 May 2023.